Elite 50% OFF Act now – get top investing tools Register Now!

Merit Medical Systems, Inc.

Contributing Author

Recent Articles by Merit Medical Systems, Inc.

Nov-13	Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY Cell-Impermeable Endoprosthesis MMSI GlobeNewswire
Nov-05	Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial MMSI GlobeNewswire
Nov-03	Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial MMSI GlobeNewswire
Oct-30	Merit Medical Reports Third Quarter 2025 Results and Updates Full-Year Guidance MMSI GlobeNewswire
Oct-15	Merit Medical Signs Asset Purchase Agreement with PENTAX Medical to Acquire C2 CryoBalloon Technology MMSI GlobeNewswire
Oct-03	Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025 MMSI GlobeNewswire
Oct-01	Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology MMSI GlobeNewswire
Sep-12	Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolisation to Treat Knee Osteoarthritis MMSI GlobeNewswire
Aug-18	First Patient Enrolled in Merit Medical's WRAPSODY (WRAP) North America Registry MMSI GlobeNewswire
Aug-07	Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology MMSI GlobeNewswire
Jul-30	Merit Medical Reports Second Quarter 2025 Results and Updates Full-Year Guidance MMSI GlobeNewswire
Jul-07	Merit Medical Names Martha Aronson as New President and Chief Executive Officer MMSI GlobeNewswire
Jul-03	Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025 MMSI GlobeNewswire
May-20	Merit Medical Acquires Biolife Delaware, L.L.C. MMSI GlobeNewswire
May-06	Merit Medical Announces Health Canada Approval of the WRAPSODY Cell-Impermeable Endoprosthesis MMSI GlobeNewswire
May-05	Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Efficacy (WAVE) Trial MMSI GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.